Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
Hulu Nicholas Hunt/Getty; Kristina Bumphrey/Getty Jim Gaffigan in 2019 and in 2024. Comedian Jim Gaffigan is the first to ...
Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.